65,437 trials
Chronic Kidney Disease · Hypertension · Hyperkalemia
Primary: Least Squares Mean Change in Serum Potassium From Baseline to Week 4 or Time of First Titration for Each Individual Starting Dose Group — -0.35; -0.51; -0.55; -0.87…
Coronary Artery Disease
Primary: Rate of Patients With Evaluable CT Scans i.e. Allowing Identification of Coronary Artery Stenosis According to Off-site Reading Assessment — 92.1; 95.4; 94.6 Percentage…
Colorectal Cancer
Primary: Duration of Bevacizumab Treatment — 6.50; 5.09; 5.95 months — p=0.8579
Healthy
Primary: AUC0-tz (Area Under the Concentration-time Curve of BI 691751 in Plasma and Whole Blood Over the Time Interval From 0 up to the Last Quantifiable Concentration) — 2830…
Post-traumatic Stress Disorder
Primary: Engagement in Evidence-based Psychotherapy for PTSD — 40 participants
Atrial Fibrillation
Primary: Acute Success — 48.8 percentage achieving success
PTSD
Primary: Clinician-Administered PTSD Scale (CAPS) — 45.5; 46.2 units on a scale — p=.849
Aging
Primary: Qualitative Changes in Dermal and Sub Dermal Collagen and Cellularity 30 Minutes After Treatment With Platelet Rich Fibrin Matrix — 0 %specimen with >25%new collagen/HPF
Diabetic Macular Edema
Primary: Overall Change in Electronic Early Treatment Diabetic Retinopathy Study Visual Acuity Letter Score From Baseline to 1-year — 13.3; 9.7; 11.2 units on a scale — p=<0.001
Haemophilus Influenzae Type b · Neisseria Meningitidis · Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine
Primary: Number of Subjects With Serum Bactericidal Assay Using Baby Rabbit Complement (rSBA-MenC) Antibody Titers Equal to or Above 1:8 — 12; 3; 200; 63 Subjects
Healthy
Primary: Percentage of Participants With Drug Related Adverse Events — 0.0; 0.0; 0.0; 0.0 Percentage of participants
Graves Disease · Hyperthyroidism
Primary: Blood Loss During Surgery — 61.67; 161.67 mL
Obstructive Sleep Apnea · Snoring
Primary: Improvements in Attention/Executive Domain Index of the Developmental Neuropsychological Assessment (NEPSY) From Baseline to 7 Months. — 7.1; 5.1 units on a scale — p=0.16
Atrial Fibrillation
Primary: Proportion of Patients With Treatment-induced Conversion of Atrial Fibrillation to Sinus Rhythm — 29; 7 participants
Hemophilia
Primary: Assessment of Bilateral Index of Maximal Peak Force — -40.86 percentage